A carregar...
tPA-A(296-299) Prevents Impairment of Cerebral Autoregulation After Stroke Through LRP Dependent Increase in cAMP and p38
BACKGROUND AND PURPOSE: The sole FDA approved treatment for stroke is tPA, but its brief therapeutic window and complications of treatment constrain its use. One limitation may be its potential to exacerbate impairment of cerebral autoregulation after stroke. Vasodilation is maintained by elevations...
Na minha lista:
| Publicado no: | Stroke |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4961526/ https://ncbi.nlm.nih.gov/pubmed/27354223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.012678 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|